Literature DB >> 33754696

An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation.

Napon Nilchan, James M Alburger, William R Roush, Christoph Rader.   

Abstract

Monoclonal antibody h38C2 is a humanized catalytic antibody that has been used to generate various immunoconjugate species such as chemically programmed antibodies, antibody-drug conjugates, and antibody-siRNA conjugates. Highly efficient and specific conjugation of h38C2 occurs at its uniquely reactive lysine (Lys) residue buried inside the antibody's catalytic pocket. We recently reported the rational mutation of this Lys residue at position 99 in the heavy chain variable domain to an arginine (Arg) residue. The Lys99Arg mutation can be site-selectively conjugated with molecules containing a hapten-like triazolyl-phenylglyoxal (TPG) unit. Here we show that this conjugation is facilitated by the unusual pH-sensitive reactivity of the Arg99 residue, consistent with an indirectly measured pKa of 5.2. The Arg99/TPG conjugation holds promise to further expand the versatility of the h38C2 conjugation platform, such as for the generation of antibody conjugates with dual payloads.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33754696      PMCID: PMC8852817          DOI: 10.1021/acs.biochem.0c00955

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  Reactive immunization: a unique approach to catalytic antibodies.

Authors:  Fujie Tanaka; Carlos F Barbas
Journal:  J Immunol Methods       Date:  2002-11-01       Impact factor: 2.303

2.  Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates.

Authors:  Pavel Strop; Shu-Hui Liu; Magdalena Dorywalska; Kathy Delaria; Russell G Dushin; Thomas-Toan Tran; Wei-Hsien Ho; Santiago Farias; Meritxell Galindo Casas; Yasmina Abdiche; Dahui Zhou; Ramalakshmi Chandrasekaran; Caroline Samain; Carole Loo; Andrea Rossi; Mathias Rickert; Stellanie Krimm; Teresa Wong; Sherman Michael Chin; Jessica Yu; Jeanette Dilley; Javier Chaparro-Riggers; Gary F Filzen; Christopher J O'Donnell; Fang Wang; Jeremy S Myers; Jaume Pons; David L Shelton; Arvind Rajpal
Journal:  Chem Biol       Date:  2013-02-21

3.  Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes.

Authors:  J Wagner; R A Lerner; C F Barbas
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

Review 4.  Cells producing their own nemesis: understanding methylglyoxal metabolism.

Authors:  Sangeeta Chakraborty; Kapudeep Karmakar; Dipshikha Chakravortty
Journal:  IUBMB Life       Date:  2014-11-07       Impact factor: 3.885

Review 5.  Residue-Specific Peptide Modification: A Chemist's Guide.

Authors:  Justine N deGruyter; Lara R Malins; Phil S Baran
Journal:  Biochemistry       Date:  2017-07-17       Impact factor: 3.162

6.  Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task.

Authors:  A Karlstrom; G Zhong; C Rader; N A Larsen; A Heine; R Fuller; B List; F Tanaka; I A Wilson; C F Barbas; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

7.  A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.

Authors:  Christoph Rader; James M Turner; Andreas Heine; Doron Shabat; Subhash C Sinha; Ian A Wilson; Richard A Lerner; Carlos F Barbas
Journal:  J Mol Biol       Date:  2003-09-26       Impact factor: 5.469

8.  Arginine modifications by methylglyoxal: discovery in a recombinant monoclonal antibody and contribution to acidic species.

Authors:  Chris Chumsae; Kathreen Gifford; Wei Lian; Hongcheng Liu; Czeslaw H Radziejewski; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2013-11-18       Impact factor: 6.986

Review 9.  Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Authors:  Paul J Thornalley
Journal:  Drug Metabol Drug Interact       Date:  2008

Review 10.  Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.

Authors:  Paresh Agarwal; Carolyn R Bertozzi
Journal:  Bioconjug Chem       Date:  2015-01-30       Impact factor: 4.774

View more
  1 in total

1.  Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation.

Authors:  Daniel F Earley; Amaury Guillou; Simon Klingler; Rachael Fay; Melanie Gut; Faustine d'Orchymont; Shamisa Behmaneshfar; Linus Reichert; Jason P Holland
Journal:  JACS Au       Date:  2022-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.